Literature DB >> 20472336

Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.

Jane L Watson1, Richard Hill, Paul B Yaffe, Anna Greenshields, Mark Walsh, Patrick W Lee, Carman A Giacomantonio, David W Hoskin.   

Abstract

Curcumin from the rhizome of theCurcuma longa plant has chemopreventative activity and inhibits the growth of neoplastic cells. Since p53 has been suggested to be important for anticancer activity by curcumin, we investigated curcumin-induced cytotoxicity in cultures of p53(+/+) and p53(-/-) HCT-116 colon cancer cells, as well as mutant p53 HT-29 colon cancer cells. Curcumin killed wild-type p53 HCT-116 cells and mutant p53 HT-29 cells in a dose- and time-dependent manner. In addition, curcumin-treated p53(+/+) HCT-116 cells and mutant p53 HT-29 cells showed upregulation of total and activated p53, as well as increased expression of p53-regulated p21, PUMA (p53 upregulated modulator of apoptosis), and Bax; however, an equivalent cytotoxic effect by curcumin was observed in p53(+/+) and p53(-/-) HCT-116 cells, demonstrating that curcumin-induced cytotoxicity was independent of p53 status. Similar results were obtained when the cytotoxic effect of curcumin was assessed in wild-type p53 HCT-116 cells after siRNA-mediated p53 knockdown. Chromatin condensation, poly (ADP-ribose) polymerase-1 cleavage and reduced pro-caspase-3 levels in curcumin-treated p53(+/+) and p53(-/-) HCT-116 cells suggested that curcumin caused apoptosis. In addition, exposure to curcumin resulted in superoxide anion production and phosphorylation of oxidative stress proteins in p53(+/+) and p53(-/-) HCT-116 cells. Collectively, our results indicate that, despite p53 upregulation and activation, curcumin-induced apoptosis in colon cancer cells was independent of p53 status and involved oxidative stress. Curcumin may therefore have therapeutic potential in the management of colon cancer, especially in tumorsthatare resistant to conventional chemotherapydue todefects inp53 expression or function. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472336     DOI: 10.1016/j.canlet.2010.04.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  38 in total

1.  Transforming Growth Factor Beta 2 Inhibits Growth and Proliferation Potential of Smad4 and p53 Mutated Human Colon Adenocarcinoma Cells.

Authors:  Ramamoorthi Ganesan; Nageswaran Sivalingam
Journal:  Pathol Oncol Res       Date:  2018-06-08       Impact factor: 3.201

2.  Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis.

Authors:  Raghu Gogada; Michael Amadori; Honghao Zhang; Anthony Jones; Alissa Verone; Jason Pitarresi; Sirisha Jandhyam; Varun Prabhu; Jennifer D Black; Dhyan Chandra
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

3.  Curcumin Induces Downregulation of E2F4 Expression and Apoptotic Cell Death in HCT116 Human Colon Cancer Cells; Involvement of Reactive Oxygen Species.

Authors:  Kyung-Chan Kim; Chuhee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2010-12-31       Impact factor: 2.016

4.  Curcumin inhibits proliferation of human lens epithelial cells: a proteomic analysis.

Authors:  Yan-hong Hu; Xiu-rong Huang; Ming-xin Qi; Bu-yuan Hou
Journal:  J Zhejiang Univ Sci B       Date:  2012-05       Impact factor: 3.066

5.  Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC.

Authors:  Jun Ma; Lynetta Phillips; Ying Wang; Tiane Dai; Janine LaPage; Rama Natarajan; Sharon G Adler
Journal:  BMC Complement Altern Med       Date:  2010-11-12       Impact factor: 3.659

6.  Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery.

Authors:  Go-Woon Kim; Goran Gocevski; Chao-Jung Wu; Xiang-Jiao Yang
Journal:  Int J Cell Biol       Date:  2010-10-05

Review 7.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

8.  Synthesis, Molecular Structure, DNA/Protein Binding, Cytotoxicity, Apoptosis, Reactive Oxygen Species, and Mitochondrial Membrane Potential of Dibenzoxanthenes Derivatives.

Authors:  Hui-Hui Yang; Bing-Jie Han; Wei Li; Yun-Jun Liu; Xiu-Zhen Wang
Journal:  J Membr Biol       Date:  2015-09-23       Impact factor: 1.843

9.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

10.  In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers.

Authors:  Sita S Withers; Daniel York; Eric Johnson; Sami Al-Nadaf; Katherine A Skorupski; Carlos O Rodriguez; Jenna H Burton; Teri Guerrero; Kriste Sein; Luke Wittenburg; Robert B Rebhun
Journal:  Vet Comp Oncol       Date:  2018-08-08       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.